SLE Clinical Trials

966 recruitingLast updated: June 9, 2026

There are 966 actively recruiting sle clinical trials across 74 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4, Phase 3, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


SLE Trials at a Glance

966 actively recruiting trials for sle are listed on ClinicalTrialsFinder across 6 cities in 74 countries. The largest study group is Not Applicable with 480 trials, with the heaviest enrollment activity in Boston, New York, and Chicago. Lead sponsors running sle studies include VA Office of Research and Development, Chinese University of Hong Kong, and University of Pittsburgh.

Treatments under study

About SLE Clinical Trials

Looking for clinical trials for SLE? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new SLE trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about SLE clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 966 trials

Recruiting

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Pediatric Obstructive Sleep Apnea
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)120 enrolled1 locationNCT05052216
Recruiting

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

SleepNeurodevelopmental DisorderNeurological Disorder+1 more
National Institute of Mental Health (NIMH)1,000 enrolled1 locationNCT01778504
Recruiting
Phase 1

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

SLESLE (Systemic Lupus)
Cullinan Therapeutics Inc.24 enrolled20 locationsNCT06613360
Recruiting
Not Applicable

Mitigation of Health Effects in Pregnant Women by Reducing Exposure to Heat and Air Pollution

Sleep Quality
University of Cyprus102 enrolled3 locationsNCT07609433
Recruiting
Phase 3

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Obstructive Sleep Apnea
Amgen250 enrolled53 locationsNCT07226765
Recruiting
Phase 1Phase 2

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)
National Heart, Lung, and Blood Institute (NHLBI)78 enrolled1 locationNCT06032923
Recruiting
Not Applicable

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

Quality of LifeElderlyCOPD+6 more
VA Office of Research and Development668 enrolled1 locationNCT04179981
Recruiting

The COSP-RBD Study: Concussions and Contact Sports in RBD vs Controls

Concussion, BrainREM Sleep Behavior Disorder
Guy's and St Thomas' NHS Foundation Trust140 enrolled1 locationNCT06270290
Recruiting
Phase 4

Lemborexant in Delayed Sleep Phase Syndrome

Delayed Sleep Phase Syndrome
University of California, San Francisco15 enrolled1 locationNCT06874855
Recruiting
Phase 3

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

ObesityOverweightSleep Apnea, Obstructive
Eli Lilly and Company800 enrolled129 locationsNCT07369011
Recruiting
Not Applicable

Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

DepressionSleepSleep Disturbance+1 more
University of Pittsburgh90 enrolled2 locationsNCT06963463
Recruiting

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Systemic Lupus Erythematosus (SLE)Primary Ovarian Insufficiency (Poi)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)100 enrolled1 locationNCT05567198
Recruiting

Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing

Sleep-disordered breathing (SDB)Obstructive Sleep Apnea (OSA)Early Risk Screening for Sleep Disordered Breathing in a Dental Setting
University of North Carolina, Chapel Hill60 enrolled1 locationNCT07581938
Recruiting
Phase 2

The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)

Chronic Obstructive Pulmonary DiseaseObstructive Sleep ApneaOverlap Syndrome
University of California, San Diego240 enrolled1 locationNCT05237505
Recruiting
Not Applicable

SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study

SleepCircadian RhythmEmotion Regulation+1 more
Baylor College of Medicine220 enrolled1 locationNCT06192745
Recruiting

Baker Gordon Syndrome Natural History Study

Rare DiseasesSleep DisorderAutism or Autistic Traits+4 more
University of Missouri-Columbia50 enrolled1 locationNCT06399952
Recruiting
Not Applicable

Type 1 Diabetes REst for Metabolic Health

Type 1 Diabetes (T1D)Sleep Health
University of Colorado, Denver50 enrolled1 locationNCT06627504
Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb223 enrolled62 locationsNCT07175285
Recruiting
Phase 3

Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea

Obstructive Sleep ApneaSleep Apnea
Yale University250 enrolled1 locationNCT07332442
Recruiting
Phase 3

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ObesityOverweightObstructive Sleep apnoea
Novo Nordisk A/S300 enrolled80 locationsNCT07571005